Source: Eur Respir J 2013; 42: 1743-1746
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Geis Steffen, Bettge-Weller Gudrun, Goetsch Udo, Bellinger Oswald, Ballmann Gisela, Hauri Anja M.. How can we achieve better prevention of progression to tuberculosis among contacts?. Eur Respir J 2013; 42: 1743-1746

Member's Comments

No comment yet.

Related content which might interest you: Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking? Source: Eur Respir J 2015; 45: 583-585 Year: 2015 Factors preventing better treatment completion among MDR TB cases in a rich-resource setting Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Can we predict tuberculosis cure? What tools are available? Source: Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018 Year: 2018 How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019 Tuberculosis causes poverty but do tuberculosis control programmes reach the poor? Source: Annual Congress 2004 - Risks for tuberculosis Year: 2004 Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination Source: Eur Respir J 2013; 42: 785-801 Year: 2013 Has the time come to shorten TB treatment and TB preventive therapy? Source: Virtual Congress 2021 – Respiratory infections Year: 2021 What are the knowledge gaps in COPD that prevent new drug development? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 How to manage a patient with COPD - early identification and how to prevent progression Source: ERS Satellites 2021 Year: 2021 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 How should we treat latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 Mobilising community networks for early identification of tuberculosis and treatment initiation in Cambodia: an evaluation of a seed-and-recruit model Source: ERJ Open Res, 6 (2) 00368-2019; 10.1183/23120541.00368-2019 Year: 2020 How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 Can we define latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Contact screening in tuberculosis. Can we identify those with higher risk? Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Does anti TNF-α treatment increase tuberculosis risk? Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007 How do we diagnose tuberculosis in early childhood? Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 How quickly do we identify and treat patients with TB ? Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009